From: Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Fatty acid | Control group | Experimental group |
---|---|---|
C14:0 (μg/mg) | 0.47 ± 0.13 | 2.39 ± 0.66** |
C15:0 (μg/mg) | 0.34 ± 0.12 | 0.18 ± 0.04** |
C16:0 (μg/mg) | 23.41 ± 7.72 | 70.08 ± 17.95** |
C17:0 (μg/mg) | 0.35 ± 0.11 | 0.41 ± 0.10 |
C18:0 (μg/mg) | 11.07 ± 4.07 | 17.33 ± 5.15** |
C18:1 n-9 (μg/mg) | 93.87 ± 19.62 | 56.69 ± 19.08** |
C18:2 n-6 (μg/mg) | 84.96 ± 27.43 | 42.12 ± 22.11** |
C18:3 n-3 (μg/mg) | 2.76 ± 1.43 | 1.07 ± 0.66** |
C20:1 n-9 (μg/mg) | 0.94 ± 0.34 | 0.97 ± 0.38 |
C20:3 n-6 (μg/mg) | 1.19 ± 0.44 | 2.10 ± 0.78** |
C20:4 n-6 (μg/mg) | 14.89 ± 5.18 | 11.10 ± 4.37 |
C20:5 n-3 (μg/mg) | 0.64 ± 0.21 | 1.06 ± 0.57 |
C22:6 n-3 (μg/mg) | 7.36 ± 4.76 | 6.57 ± 3.95 |
TFA (μg/mg) | 242.24 ± 14.44 | 212.79 ± 11.95** |
SFA (μg/mg) | 35.64 ± 6.15 | 91.11 ± 6.92** |
UFA (μg/mg) | 206.60 ± 14.62 | 121.68 ± 12.07** |
MUFA (μg/mg) | 94.81 ± 10.53 | 57.66 ± 11.46** |
PUFA (μg/mg) | 111.80 ± 10.51 | 64.02 ± 8.38** |
SFA/TFA ratio (%) | 14.73 ± 2.44 | 42.89 ± 3.26** |
UFA/TFA ratio (%) | 85.27 ± 2.44 | 57.11 ± 3.43** |
PUFA/SFA ratio (%) | 323.23 ± 66.64 | 70.03 ± 11.05** |
MUFA/SFA ratio (%) | 273.63 ± 59.59 | 63.91 ± 14.62** |
n-6/n-6 ratio (%) | 18.04 ± 5.04 | 28.15 ± 8.90** |
n-3/n-3 ratio (%) | 286.69 ± 67.02 | 740.80 ± 58.75** |
n-6/n-3 ratio (%) | 188.29 ± 15.51 | 143.33 ± 13.66** |